search

Active clinical trials for "Digestive System Neoplasms"

Results 261-270 of 288

Use of the EnLightTM and LightPathTM Imaging Systems in Gastrointestinal Tumour Surgery

Gastric CancerPancreatic Cancer2 more

This study will evaluate the performance of the EnLightTM and LightPathTM Imaging Systems in detecting tumour lesions in patients with gastric, pancreas, bile duct or duodenal cancer. EnLightTM will be used to detect positron emission and the LightPathTM system to detect Cerenkov Luminescence. Both are emitted by the Positron Emission Tomography (PET) agent. The study will also evaluate the patient safety and radiation safety of the EnLightTM, and the safety for the device operators and surgical staff of the LightPathTM Imaging System.

Withdrawn10 enrollment criteria

Nutritional Preferences and Product Accessibility in Oral Nutritional Supplements in Participants...

Breast CarcinomaCholangiocarcinoma5 more

This trial studies nutritional preferences and product accessibility in oral nutritional supplements in participants with breast, colorectal, upper gastrointestinal, or prostate cancer. Learning what participants like and dislike about their current or past used nutritional supplements may help doctor know how to improve them.

Withdrawn6 enrollment criteria

Retrospective Review of Gastrointestinal System Endoscopy Procedures

EndoscopyColonoscopy6 more

The aim of the study is retrospectively evaluating all features of endoscopic and pathological diagnoses of cases who underwent upper and lower gastrointestinal endoscopy.

Completed4 enrollment criteria

Assessment of Postoperative Lymphopenia as Risk Factor for Postoperative Infections

Cancer of the Digestive SystemThoracic Diseases

Postoperative infections are one of the most common complications in thoracic and digestive cancer surgery. Former studies have demonstrated that inflammatory response is altered during peri-operative period causing lymphopenia. It has been suggested that lymphopenia may contribute to postoperative infection. To date, no one has proved it in a multivariate analysis. The aim of this study is to determine if lymphopenia is associated with postoperative infections in thoracic and digestive cancer surgery.

Completed5 enrollment criteria

Mortality Predictions With Scorring Indices in Gastrointestinal Tumours

Gastrointestinal Tumours

The ASA-PS, SORT and Sarcopenia scores of the patients who will undergo surgery for a gastrointestinal tumor will be recorded. Thus, the correlation between preoperative indices and mortality/morbidity will be evaluated.

Completed3 enrollment criteria

Improvement of Colonoscopy Preparation by New Media (APP)

Gastrointestinal Neoplasms

Feasibility of an newly programmed offline application for smartphones (SPA, APP) for colonoscopy preparation offering a 5 day guidance prior colonoscopy containing dietary- and behavioral recommendation.

Unknown status6 enrollment criteria

A Randomized, Open-label Phase III Trial of Mapisal® Versus an Urea Hand-foot Cream as Prophylaxis...

the Treatment Hand-foot Syndrome Patients With Gastrointestinal Tumors or Breast CancerWho Are Treated With Capecitabine

The purpose of this study is the examination of Mapisal® versus urea hand-foot cream as prophylaxis for capecitabine-induced hand-foot syndrome (HFS) in patients with gastrointestinal tumors or breast cancer, to assess the efficacy of Mapisal®. Mapisal® is a medical device that is approved for the prophylaxis and treatment of HFS. Initial clinical data and case studies on the treatment and prophylaxis of Caelyx-induced HFS have been impressive. Because the pathomechanism of HFS caused by capecitabine is the same as for Caelyx-induced HFS, it is expected reason that administering Mapisal® should result in a significant reduction of HFS caused by capecitabine. The urea hand-foot cream was selected for the standard arm, because it is used commonly, is accepted by patients, and seems to have a positive influence on the severity of the HFS in the experience of many oncologists.

No longer available20 enrollment criteria

Retrospective Analysis of Colorectal Cancer Screening Results

Colorectal CancerAdvanced Adenocarcinoma4 more

The purpose of this study is to retrospectively analyze colorectal cancer screening data of 40-74 year old population in Shipai Town, Dongguan City. In this study, the data of SDC2 Gene Methylation Test and Fecal Immunochemistry Test (Q-FIT) were screened from about 11,000 subjects who participated in Colorectal Cancer Screening in Shipai Town People's Livelihood Project from May 2021 to May 2022. Data from 822 subjects with positive SDC2 Gene Methylation Test and/or positive Fecal Immunochemistry Test (Q-FIT) results and with colonoscopy and/or pathological results were selected for retrospective analysis. This retrospective study evaluated the screening performance of SDC2 Gene Methylation Test and/or Fecal Immunochemistry Test (Q-FIT) for colorectal cancer using colonoscopy and/or pathological results as the clinical standard method.

Completed6 enrollment criteria

Functional MRI of Hypoxia-mediated Rectal Cancer Aggressiveness

Rectal DiseasesRectal Neoplasms2 more

The purpose of this study is to establish a reliable method for detection of rectal cancer patients with aggressive tumor at risk of metastatic disease and death by functional MRI.

Completed8 enrollment criteria

Evaluation of Predictive Visual Analog Scale (VAS) for Determining the Ingesta of Patients Carrying...

Digestive System Neoplasms

The main objective of our study is to determine if the evaluation of ingesta of cancer patients by VAS (on the day of hospitalization) is able to predict the actual ingesta of patients during hospitalization (for patients malnourished, at risk of malnutrition or risk free).

Completed5 enrollment criteria
1...26272829

Need Help? Contact our team!


We'll reach out to this number within 24 hrs